Beth C Seidenberg

Beth C Seidenberg has an estimated net worth of $344 Million. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., ACELYRIN, Inc., Vera Therapeutics, Inc., Atara Biotherapeutics, Inc., Progyny, Inc., BIOCRYST PHARMACEUTICALS INC, ARMO BioSciences, Inc., TESARO, Inc., Epizyme, Inc., AMGEN INC, and Kyverna Therapeutics, Inc..

2023 was Beth C Seidenberg's most active year for acquiring shares with 38 total transactions. Beth C Seidenberg's most active month to acquire stocks was the month of May. 2021 was Beth C Seidenberg's most active year for disposing of shares, totalling 21 transactions. Beth C Seidenberg's most active month to dispose stocks was the month of December. 2016 saw Beth C Seidenberg paying a total of $50,033,049.02 for 1,460,327 shares, this is the most they've acquired in one year. In 2018 Beth C Seidenberg cashed out on 8,551,366 shares for a total of $213,514,690.00, their largest year based on trade value.